SHOP APOTHEKE EUROPE N.V. issued unsecured, non-subordinated convertible bonds on 14 January 2021. This instrument allows longer-term financing at attractive conditions and is an interesting investment opportunity for investors.
The Company will have the option to redeem all, but not some only, of the Bonds at their principal amount in accordance with the terms and conditions of the Bonds (i) at any time on or after March 10, 2025 if the price of the listed share of the Company exceeds 130% of the then prevailing conversion price over a specified period or (ii) if 15% or less of the aggregate principal amount of the Bonds remains outstanding. Holders of the Bonds will be entitled to require an early redemption of their Bonds at their principal amount on the fifth anniversary of the Bonds' issue.
Unless previously redeemed, or purchased and cancelled, the Bonds will be convertible at the option of the holder into Settlement Shares.
The Company is entitled to make a cash payment in lieu of delivering the Settlement Shares if and to the extent on settlement date the Company is unable to deliver Settlement Shares upon conversion.
SHOP APOTHEKE EUROPE N.V. issued unsecured, non-subordinated convertible bonds on 12 April 2018 and on 10 April 2019. This instrument allows longer-term financing at attractive conditions and is an interesting investment opportunity for investors.
Under the terms of the bonds, the Company may redeem the convertible bonds at their principal amount (plus accrued interest not yet paid) at any time (i) on or after May 30, 2021 if the price of the Company's shares exceeds 130% of the then applicable conversion price during a specified period or (ii) if 15 % or less of the total principal amount of the convertible bonds is outstanding.
Unless previously repaid or purchased and cancelled, the convertible bonds will be converted into shares at the option of the holder. Instead of the delivery of shares, (partial) cash payment may also be made under certain conditions.